RECRUITING

Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

Talk to us

Conditions

Sickle Cell Trait

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.

Official Title

Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

Quick Facts

Study Start:2023-04-01
Study Completion:2025-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06071377

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Are willing to voluntarily participate and sign the study consent
  2. 2. Know/suspect they have SCT and are willing to get tested to confirm/learn about their SCT status
  3. 3. Be willing and able to participate in the 2- year study plan.
  4. 4. Adults ages 18-65
  1. 1. Unwilling to sign consent
  2. 2. Known end-stage renal disease or dialysis
  3. 3. Known SCD (including sickle cell-beta thalassemia)
  4. 4. People who do not have SCT

Contacts and Locations

Study Contact

Julie Kanter, MD
CONTACT
(202) 596-1548
jkanter@sicklecellcenters.org

Principal Investigator

Julie Kanter, MD
PRINCIPAL_INVESTIGATOR
National Alliance for Sickle Cell Centers

Study Locations (Sites)

University of Alabama
Birmingham, Alabama, 35294
United States
Loma Linda University Health Care
Loma Linda, California, 92354
United States
Nemours Children's Hospital
Wilmington, Delaware, 19803
United States
Indiana University
Indianapolis, Indiana, 46202
United States
Johns Hopkins University
Baltimore, Maryland, 21224
United States
University of North Carolina
Chapel Hill, North Carolina, 27599
United States
Duke University
Durham, North Carolina, 27710
United States
East Carolina University
Greenville, North Carolina, 27834
United States
Nationwide Children's Hospital
Columbus, Ohio, 43205
United States

Collaborators and Investigators

Sponsor: National Alliance for Sickle Cell Centers

  • Julie Kanter, MD, PRINCIPAL_INVESTIGATOR, National Alliance for Sickle Cell Centers

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-01
Study Completion Date2025-04

Study Record Updates

Study Start Date2023-04-01
Study Completion Date2025-04

Terms related to this study

Additional Relevant MeSH Terms

  • Sickle Cell Trait